IL22 and lung disorder: However, if a patient presents with a known disease commonly leading to PH at later stages, e.g., left heart or lung disease as well as chronic thromboembolism, the inclusion of IL-22 as additional biomarker for therapy surveillance could be useful to detect PH and consecutive right heart failure development.